Exposure of the early gestation ovine fetus to exogenous glucocorticoids induces changes in postnatal cardiovascular physiology. We sought to characterize coronary artery vascular function in this model by elucidating the contribution of nitric oxide and reactive oxygen species to altered coronary vascular reactivity and examining the proliferative potential of coronary artery vascular smooth muscle cells. Dexamethasone (dex, 0.28 mg/kg/d for 48 h) was administered to pregnant ewes at 27-28 d gestation (term 145 d). Coronary arteries were isolated from 1-2 wk old dex-exposed offspring and aged matched controls. Compared to controls, coronary arteries from dex-exposed lambs demonstrated enhanced vasoconstriction to endothelin-1 and acetylcholine that was abolished by endothelial removal or preincubation with the nitric oxide synthase inhibitor L-NNA, membrane permeable superoxide dismutase + catalase, or apamin + charybdotoxin, but not indomethacin. The rate of coronary vascular smooth muscle cell (VSMC) proliferation was also significantly greater in dex-exposed lambs. Protein levels of the proliferating cell nuclear antigen were increased and α-smooth muscle actin decreased in dex-exposed coronary VSMC, consistent with a proliferative state. Finally, expression of the NADPH oxidase Nox 4 but not Nox 1 mRNA was also decreased in coronary VSMC from dex-exposed lambs. These findings suggest an important interaction exists between early gestation glucocorticoid exposure and reactive oxygen species that is associated with alterations endothelial function and coronary VSMC proliferation. These changes in coronary physiology are consistent with those associated with the development of atherosclerosis and may provide an important link between an adverse intrauterine environment and increased risk for coronary artery disease.
Introduction
Beginning with epidemiologic examination of birth weight data (2, 3) , and progressing through numerous animal studies (16) , research regarding developmental programming of adult-onset diseases has expanded greatly in the last 25 years. There are substantial published data indicating that an adverse intrauterine environment predisposes to the onset of adult diseases that include, but are not limited to, hypertension, atherosclerosis, diabetes and metabolic syndrome (16) . Two models commonly employed in this area of research are altered maternal nutrition and augmented steroid hormone exposure. The phenotypic consequences of either of these challenges are surprisingly similar, leading to the hypothesis that they may share key common mechanisms (6, 10, 29) .
Understanding the mechanisms that link maternal conditions and disease in the offspring is confounded by the complexity and interrelations of diseases like hypertension and atherosclerosis. One difficulty lies in isolating primary, underlying defects and separating them for secondary effects of the resultant phenotype. For example, hypertension may result directly from endothelial dysfunction or another cause that then contributes to endothelial dysfunction. It is therefore advantageous to study offspring at a young age, prior to the development of overt phenotypes, to identify primary defects that have been programmed in utero.
We have examined an ovine model of developmental programming that utilizes brief exposure of ewes to exogenous steroids early in gestation and results in significantly elevated blood pressure in the offspring at 4 months (6, 22, 25) . When studied during the first two weeks following birth, prior to the development of hypertension, these lambs display marked alterations in vascular reactivity and autonomic function (25, 30) . An intriguing observation is the disparity in vasoreactive 5 responses among various vascular beds. Compared to control animals, coronary artery segments from dex-exposed lambs display an increased vasoconstrictive response to endothelin-1 (25) , whereas mesenteric and femoral artery responses are decreased (30) .
These divergent responses may be related, in part, to vessel-specific differences in the nitric oxide-cGMP pathway. Our findings, and those from other laboratories (reviewed in
McMillen and Robinson (16) ), have suggested that nitric oxide availability and endothelial function are early effectors leading toward hypertension and coronary artery dysfunction (30) . Studies from other investigators have also suggested an important role for altered nitric oxide and reactive oxygen species signaling in systemic vascular dysfunction in programmed animals, though examination of pathways in the coronary vasculature from these animals is limited. (8, 9, 21) .
In the present study, we sought to further characterize coronary artery vascular function in early gestation dexamethasone-exposed lambs. Specifically, the contributions of nitric oxide and reactive oxygen species to altered vascular reactivity were examined. Because of its role in atherosclerosis, the proliferative potential of coronary artery vascular smooth muscle cells was also explored.
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Methods
Sheep model
All procedures were performed within the regulations of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the University of Iowa Animal Care and Use Committee. Ewes were bred and maintained at the Iowa State University Agricultural Station as described previously (30) . Exogenous steroid exposure of the pregnant ewe was accomplished by infusion of dexamethasone (0.28 mg·kg 
Coronary artery ring myography
Between 8-15 days after birth, the lambs were euthanized with intravenous pentobarbital sodium (50 mg/kg; Abbott Laboratories, Abbott Park, IL). The circumflex coronary artery was quickly harvested and the loose adventitia and connective tissue was removed before sectioning into 3 mm rings. In some artery segments, the endothelium was removed by rubbing with a rubber policeman. The rings were mounted in individual 18 ml isolated water-jacketed chambers and contractile forces were measured using 32 
Vascular smooth muscle cell culture
The left anterior descending coronary artery and second and third order mesenteric arteries were harvested, loose outer connective tissue removed, and the vascular smooth muscle cells (VSMC) enzymatically dispersed with a mixture of collagenase and elastase as described previously (25) . Cells were plated in 100 mm dishes, grown to near confluence in Delbecco's Modified Eagle's Medium (DMEM, Hyclone, Logan UT) + 10% fetal bovine serum + 100 U/ml penicillin + 100 µg/ml streptomycin, and then expanded to T150 flasks and grown to confluence. These first passage cells (P1) were lifted with trypsin and cryopreserved in aliquots using
Recovery™-cell culture freezing medium (Invitrogen Corp., Carlsbad, CA).
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At a later time aliquots (2×10 6 cells/2 ml vial) were thawed and plated in T75 flasks and fed with VSMC media (DMEM with high glucose + 5% fetal bovine serum + MEM vitamins + non-essential amino acids + 25 mM HEPES + 100 U/ml penicillin + 100 µg/ml streptomycin) until they reached near confluence (75-90%). Freezing and subsequent thawing of cells was performed to allow all samples for proliferations studies (see below) to be performed at the same time, under as similar conditions as possible, including use of same reagents and serums. In order to synchronize each culture for subsequent seeding, serum was removed for 48 hours before lifting with trypsin and seeding for study of the passage 2 (P2) cells.
Characterization of coronary VSMC by immunofluorescence
Because enzymatic dispersion of an arterial segment would initially release endothelial cells, fibroblasts and VSMCs, it was important to characterize our P2 cultures using immunofluorescent cell type-specific markers. Cells grown to near confluence in 35 mm dishes were washed 3× and fixed with 5 min exposure to 100% methanol. Dual labeling cocktails of primary and secondary antibodies were designed for detection of α-smooth muscle actin and von Willebrand factor. The primary antibody for von
Willebrand factor was raised in rabbit and the secondary, which was conjugated to rhodamine, was directed at a rabbit primary and species cross adsorbed so that it did not cross react with any mouse primary. The primary antibody for α-smooth muscle actin was raised in mouse and the secondary, which was conjugated to fluorescein, was directed at a mouse primary and species cross adsorbed so that it did not cross react with any rabbit primary. All four antibodies were obtained from Millipore Corporation (Billerica, MA). Fluorescence images were acquired using SPOT software and camera (Diagnostic Instruments, Inc., Sterling Heights, MI) attached to a Nikon Eclipse E400
fluorescence-capable microscope.
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Cell proliferation
After serum starvation (48 hours) of a near-confluent T25 flask of second passage VSMC, cells were lifted with trypsin and seeded into 12 well plates at 5000 cells per well. VSMC media was changed every other day. On the days between media changes, one well of cells was lifted with trypsin and counted in a Beckman Coulter Z2 series dual threshold particle counter (Beckman Coulter, Fullerton, CA). VSMC were counted between thresholds set at 12-30 µm in diameter based on the size-frequency distribution showing a distinct single population of particles with boundaries that were clearly distinct from debris.
Immunoblotting
Near confluent (~80%) second passage VSMCs were harvested into phosphate buffered saline (PBS) using a cell scraper. Because of differing rates of cell proliferation, cells were therefore harvested on dissimilar days in culture. Cells were pelleted by centrifugation and sonicated in a buffer containing 50 mM Tris, 150 mM NaCl, 0.2 mg/ml sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 0.4 mM DTT, 100 µg/ml PMSF, 2 µg/ml aprotinin, and 20 µg/ml leupeptin. Protein samples (5 µg/lane) were separated by SDS-PAGE and transferred to nitrocellulose membranes (Whatman Inc., Florham Park, NJ). The Odyssey infrared 2-color imaging system and reagents (LI-COR, Lincoln, NE) were used for immunoblotting and subsequent quantitation of specific proteins as previously described (19) . Briefly, membranes were blocked with Odyssey blocking buffer for 1 hour at room temperature followed by incubation in a 1:5000 dilution of an antibody for proliferating cell nuclear antigen (PCNA; PC10 mouse mAb #2586;
Cell Signaling Technology, Inc., Danvers, MA) or 1:1000 for Cyclin E1 (# 4129, Cell
Signaling Technology) overnight at 4ºC. The anti-mouse secondary antibody (Odyssey, 10 700 nm) was used at a dilution of 1:1000 for 1 hour at room temperature. Following quantitation of the band of interest, the membrane was washed and reprobed overnight (4ºC) with a 1:5000 dilution of a α-actin antibody (rabbit polyclonal; Abcam, Inc., Cambridge, MA) designed as a loading control. The anti-rabbit secondary antibody (Odyssey, 800 nm) was applied at a dilution of 1:1000 for 1 hour at room temperature.
As an independent evaluation of equal loading, the membranes were stained with Ponceau S.
qRT-PCR
Total RNA was purified from second passage VSMC using the QIAzol and 
11
ATGTATCAGGAGGGCTGCTGAAGTATCAAA. Relative standard curves were generated for each run using pooled RNA harvested from tissues where the target molecules were abundantly expressed (NOX4-kidney; NOX1-kidney; GAPDH-VSMC).
All individual samples were run in triplicate and each final average was calculated from 3 separate reverse transcription reactions that were generated from 3 separate RNA harvests. When compared across equally loaded (by quantitated RNA amounts) control and programmed cells, there was no significant change in GAPDH RNA quantity, supporting its use as an endogenous control for the NOX1 and NOX4 quantification.
Chemicals
Fetal bovine serum was from Atlanta Biologicals (Lawrenceville, GA). The cell culture supplements HEPES, penicillin/streptomycin, and non-essential amino acids were from Gibco/Invitrogen. All other chemicals were from Sigma-Aldrich (St. Louis, MO).
Data analysis
All values are presented as mean ± SE. Statistical comparisons were performed by Student unpaired, two-tailed t-test or analysis of variance (ANOVA) with a post-hoc Tukey's test. Dose response curves were analyzed by area under the curve. A value of p < 0.05 was considered significant.
Results
Control and dexamethasone-exposed lambs did not differ significantly in age (11.5 ± 0.5 d vs.10.9 ± 2.7d, respectively), or weight (9.1 ± 1.7 kg vs. 8.2 ± 2.8 kg, respectively) on the day of sacrifice. The control group (n = 8, 4 males) was comprised of 4 twin deliveries while the dexamethasone group (n = 7, 4 males) was comprised of 1 triplet and 2 twin deliveries.
Vascular Reactivity
Responses of the coronary artery segments to KCl (120mM KCl) were not significantly altered by antenatal dex-exposure (data not shown) allowing for normalization of subsequent responses to be expressed as %KCl response. The contractile responses to ET-1 and Ach were significantly enhanced in intact coronary arteries from dex-exposed compared to control animals ( Figure 1A, 1G) . However, this difference in responsiveness was not observed in endothelial denuded vessels ( Figure   1B , 1H) or in the presence of L-NNA ( Figure 1C, 1I ), PEG-SOD + PEG-Cat ( Figure 1D , 1J) or apamin + charybdotoxin ( Figure 1E, 1K ). Contractile responses in the presence of indomethacin were significantly increased in both groups (p<0.05), although the differences between control and dex-exposed vessels remained ( Figure 1F, 1L) . 
Vascular Smooth Muscle Cell Proliferation
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After synchronization by 48hr of serum starvation, cells were counted every other day for 12 d while in 10% serum-containing medium. The average cell proliferation curves for control and dex-exposed VSMC lines are depicted in Figure 3 . Cells derived from dex-exposed lamb coronary arteries proliferated significantly faster than those from control animals ( Figure 3A , p < 0.05). The number of cells per well was significantly different at days 10 and 12, at a time when cells still appeared to be growing exponentially. In contrast, proliferation of VSMC isolated from second-and third-order mesentery arteries from these same animals, and performed in parallel with the coronary studies was not different between groups ( Figure 3B ).
Immunoblotting
Expression of proliferating cell nuclear antigen (PCNA) was determined in coronary VSMC lysates derived from serum exposed control and dex-exposed cell lines (Figure 4 ). The single band at 37 kDa is consistent with the predicted size of PCNA.
PCNA protein was significantly more abundant in the dex-exposed cells compared to controls. Protein levels of β-actin (band near 50 kDa), used as a loading control, were similar between groups. When expressed as PCNA/α-actin, the ratio is almost 6-fold greater in dex-exposed compared to control VSMC (Figure 4 , bottom). Expression of smooth muscle α-actin, a marker of differentiation state, was also significantly decreased in dex-exposed coronary VSMC compared to control (15.5± 0.6 vs.18.3 ± 1.6 arbitrary units, respectively, p< 0.05). Expression of another proliferation marker, Cyclin E1, a protein necessary for the transition from G1 to S-phase of the cell cycle, tended to increase in cultured VSMC from dex-exposed compared to control animals, though failed to reach statistical significance (5.62 ± 1.02 vs 3.40 ± 0.47 arbitrary units, respectively p=0.07)
mRNA expression
Because the SOD + catalase results suggested a role for ROS production in regulating the programmed differences in coronary artery reactivity, we examined the expression of the NADPH oxidases Nox1 and Nox4 in coronary VSMC. Of note, Nox1
and Nox4, enzymes that normally produce ROS in VSMC, have also been shown to be associated with proliferation and differentiation in VSMC (4). Using qRT-PCR, we found the ratio of Nox4/GAPDH was significantly lower in dex-exposed VSMC compared to controls (80 ±15 a.u. vs 440 ± 125 a.u., p < 0.05) while no difference was detected in Nox 1 expression. Attempts at quantitating Nox1 and Nox4 protein by immunoblot using commercially available antibodies were unsuccessful. We previously reported enhanced ET-1 and Ach contractile responses of coronary artery rings isolated from dex-exposed lambs (25) . In those studies, evidence suggestive of both endothelial and smooth muscle dysfunction was present, although endothelial effects were not evaluated directly. We have now extended the studies to constriction was greater in intact dex-exposed coronaries compared to controls but that the difference was completely abrogated by denuding of the endothelium suggests a primary role for endothelial dysfunction in contributing to the enhanced contractility in dex-exposed vessels. Endothelial dysfunction is typically thought to be related to impairment in the generation and function of NO as a vasodilator(27). Along these lines, we found that preincubation of coronary arteries with the NOS inhibitor, L-NNA, abolished differences in contraction to ET-1 and Ach between groups. Of note, we previously demonstrated a significant decrease in endothelial eNOS protein expression in dex-exposed newborn coronary arteries, which in turn may result in decreased NO production (25) . It is also possible that NO bioavailability may be related to enhanced inactivation resulting from interaction with superoxide. Increased ROS production may decrease NO bioavailability by 3 distinct mechanisms (32) . First, superoxide may react directly with NO to form peroxynitrite anions. Second, ROS may cause oxidative degradation of tetrahydrobiopterin, an essential cofactor for eNOS, thus causing an "uncoupling" of the enzyme. Finally, ROS may cause a redox-dependent inhibition of the enzyme dimethylarginine dimethylaminohydrolase, which is followed by an increase in concentration of the endogenous eNOS inhibitor asymmetric dimethylarginine. Our previous observation of enhanced endothelial superoxide production in dex-exposed lambs is consistent with these mechanisms contributing to our findings.
Discussion
The failure of indomethacin to abrogate any differences in responsiveness between control and dex-exposed coronary arteries suggests little role for programmed changes in prostaglandin production contributing to vascular dysfunction in the dex-exposed group. However, differences in contractile responses between groups were eliminated by preincubation with apamin + charybdotoxin and with membrane permeable superoxide dismutase (PEG-SOD) and catalase (PEG-catalase), indicating an important role of EDHF, including H 2 O 2 . Specifically, with both apamin + charybdotoxin and PEG-SOD + PEG-catalase, the differences in contractility between control and dex-exposed vessels were obviated not by reducing the response of the dex group but by enhancing the response of control vessels, suggesting a fundamental deficiency in H 2 O 2 -mediated EDHF activity in dex-exposed coronary arteries. A potential role for EDHF in regulating the observed differences in vascular function is intriguing and to our knowledge has not been explored in animal models of developmental programming. The molecular nature of EDHF is controversial and likely encompasses a variety of soluble factors, including arachadonic acid metabolites, potassium and H 2 O 2 , as well as conducted hyperpolarization moving from endothelial cells to VSMC via gap junctions(7). H 2 O 2 has been identified as a particularly important EDHF in the coronary vasculature (17, 18) .
While it has been suggested that H 2 O 2 may act to maintain tissue perfusion in states of oxidative stress (when NO mediated vasodilation is impaired), our findings suggest that both of these complementary pathways are impaired in the programming of coronary dysfunction.
In addition to endothelial dysfunction, smooth muscle cell migration and proliferation are integral to atherogenesis(11). We found that cultured coronary VSMC from dex-exposed lambs proliferated at a greater rate than those from control animals.
The finding of increased levels of PCNA, which is expressed mainly in the S-phase of the cell cycle and serves as a proliferative marker, is consistent with the proliferation results(1). We attempted to further define the VSMC phenotype by examining expression of smooth muscle α-actin in the presence and absence of serum. Smooth muscle α-actin represents a marker of differentiation, increasing in expression with elevation of myofilament density(12, 31). The finding that the level of this protein was decreased in dex-exposed coronary VSMC in the presence of serum is suggestive of a tendency for these cells to remain in a dedifferentiated, proliferative state. The mechanism(s) regulating the proliferative response in dex-exposed coronary VSMC are not known. However, because VSMC growth in culture is clearly independent of endothelial influences, the programming stimulus appears to induce a VSMC-specific change in proliferative capacity. Because of accumulating evidence that nonphagocytic NADPH oxidase generated ROS may directly or indirectly serve as an important signaling molecule in VSMC, regulating migration, proliferation and contraction, expression of Nox1 and Nox4 was also evaluated (15, 33) . in Nox4 expression we observed in cells from dex-exposed animals would be consistent with these cells being maintained in a dedifferentiated, or proliferative state, the state that VSMC are in during early neointimal formation (31) . Additional studies on the role of Nox isoforms have identified Nox 1 to be an important in regulator of VSMC migration and neointimal formation (14, 28) . Given these findings, we postulate that coronary
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VSMC from dex-exposed newborn lambs may remain in a relative de-differentiated state and may be "primed" for proliferation and/or neointimal formation. Such a condition, if present in humans after exposure to an adverse perinatal environment, may contribute to the increased incidence of atherosclerosis and death from cardiovascular disease seen in former low birth weight infants.
The absence of difference in VSMC proliferation rates obtained from mesenteric arteries of control and dex-exposed animals provides additional evidence for the vesselspecific effect of the programming stimulus. Interestingly, we previously described in newborn lambs that mesenteric vascular reactivity to ET-1 was not altered following early gestation exposure to dexamethasone, a sharp contrast to that observed in coronary arteries from the same animals (30) . Thus, both the VSMC proliferation and vascular reactivity programming effects of antenatal corticosteroids appear to be vessel specific. This finding likely relates to the different embryological origins of the vessels, the heterogeneity in phenotypes of VSMCs within the arteries, and epigenetic modifications of the genome in response to glucocorticoid exposure (34) .
We acknowledge a number of limitations of the present study. First, sheep are an unusual species to examine factors contributing to coronary vascular dysfunction.
Although sheep, to our knowledge, do not develop coronary atherosclerosis, underlying pathways and biology can still be examined. Second, although our results suggest an important role of reduced endothelial NO function , we did not directly measure levels of NO in the isolated vessels. Third, because of a paucity of reagents for the species, were unable to quantitate protein levels of Nox 1 and Nox4. It also should be recognized that far more characterization and phenotyping of the VSMCs from dex-exposed animals is needed to make conclusions regarding the effect of the in utero environment on these cells. However, the model also provides a number of strengths. For example, because of the size of the lamb heart and coronary arteries, we were able to perform the wire 20 myography and isolate coronary VSMC from the same animals. In addition, the tissues were obtained from newborn lambs before the development of the overt hypertensive phenotype. Thus, alterations in vascular function and VSMC proliferation and gene expression are primary changes related to early gestation dexamethasone exposure and not secondary changes related to the presence of hypertension.
Perspectives and Significance
The present studies provide novel information regarding early gestation dexamethasone exposure-induced alterations in coronary artery function. We have demonstrated that early gestation dex-exposure elicits coronary endothelial dysfunction resulting from an apparent reduction in endothelial NO and EDHF bioavailability. Ex vivo coronary VSMC proliferation was also selectively enhanced. These changes are present prior to the development of an overt in vivo vascular phenotype, suggesting that these alterations in physiology are a primary response to the programming stimulus and not secondary to the development of hypertension, atherosclerosis or other disease state.
Early gestation dexamethasone exposure, or any other "programming" event is unlikely to directly cause coronary artery disease, just as in humans low birth weight does not cause atherosclerosis. Rather, a sub-optimal intrauterine environment may predispose to, or increase the risk for development of coronary artery disease in response to known risk factors for heart disease. Such a hypothesis has not, to our PCNA Expression
